After getting approval from the ethical committee, the patients will be approached, and educated   about the study and their consent will be obtained.Following preliminary screening for the complaints develops after Covid 19 using specified selection criteria, eligible 50 patients will be recruited in the study.The study is proposed to be conducted both in IPD and OPD of the National Institute of Homoeopathy, Kolkata and the period of the study will be one year. Our study included patients who were having history of COVID-19 (diagnosed by RTPCR or history of having COVID like manifestations). 50 patients of 18-65 years of age will be included in the study.The patients will be interviewed about whether he/she had History of COVID-19 (diagnosed by RTPCR or history of having COVID like manifestations) and the symptoms remain after they have had COVID-19 has to be noted down.Participants fulfilling the inclusion & exclusion criteria shall be included in the study. Case-taking of the participants will be done as per strict Homoeopathic principles and data as per Preliminary details, special questionnaires and scoring according to the Modified Medical Research Council (MCR) dyspnoea scale and MONARCH. Clinical examination or relevant investigations will be done as per requirement.Medicine will be prescribed in Centesimal or Fifty Millesimal potency, maintaining the strict Homoeopathic principles (regarding dose and repetition).The investigator will be the only authority for collection, recording and assessment of the data.Follow up on a regular basis (every 4weeks) for a minimum of 6 months (In case of50 millesimal before repeating the next potency patient shall consult telephonically). After completion of study the result will be represented by using different statistical methods after analysing the results.